THIRD HARMONIC BIO
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the bodyโs interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases.
THIRD HARMONIC BIO
Industry:
Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.thirdharmonicbio.com
Total Employee:
11+
Status:
Active
Total Funding:
155 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API Google Tag Manager Google Maps Content Delivery Network IPv6 Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Included Health
Included Health is a concierge healthcare platform focused on raising care equality for your LGBTQ+ employees.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Boxer Capital
Boxer Capital investment in Series B - Third Harmonic Bio
RTW Investments
RTW Investments investment in Series B - Third Harmonic Bio
General Atlantic
General Atlantic investment in Series B - Third Harmonic Bio
Biotechnology Value Fund
Biotechnology Value Fund investment in Series B - Third Harmonic Bio
Ajax Health
Ajax Health investment in Series B - Third Harmonic Bio
RA Capital Management
RA Capital Management investment in Series B - Third Harmonic Bio
Commodore Capital
Commodore Capital investment in Series B - Third Harmonic Bio
Deep Track Capital
Deep Track Capital investment in Series B - Third Harmonic Bio
Biotechnology Value Fund
Biotechnology Value Fund investment in Series A - Third Harmonic Bio
OrbiMed
OrbiMed investment in Series A - Third Harmonic Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-04 | Third Harmonic appoints Christopher Murphy as CFO |
| 2022-06-06 | Third Harmonic Bio Appoints Edward R. Conner, M.D., as Chief Medical Officer |
| 2022-03-09 | Third Harmonic Bio Appoints Robert Ho as Chief Financial Officer |
Official Site Inspections
http://www.thirdharmonicbio.com Semrush global rank: 2.93 M Semrush visits lastest month: 5.45 K
- Host name: 113.243.231.35.bc.googleusercontent.com
- IP address: 35.231.243.113
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Third Harmonic Bio"
Third Harmonic Bio Announces Leadership Changes
Oct 31, 2023 Additionally, the company announced that Robert Ho, Chief Financial Officer, will depart the organization on November 10, 2023. The company has initiated executive searches โฆSee details»
Third Harmonic Bio Announces Plan of Liquidation and Dissolution ...
Apr 14, 2025 Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting of Stockholders on June 5, โฆSee details»
Third Harmonic Bio - Crunchbase Company Profile & Funding
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation.See details»
Third Harmonic Bio (THRD) Company Profile & Description - Stock โฆ
Apr 17, 2025 1700 Montgomery Street, Suite 210 San Francisco, California 94111 United StatesSee details»
Org Chart Third Harmonic Bio - The Official Board
The organizational chart of Third Harmonic Bio displays its 14 main executives including Natalie Holles, Christopher Murphy, Dennis Dean and Michael TurnerSee details»
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 โฆ
Feb 11, 2025 THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU). Company initiating process to leverage balance sheet strength โฆSee details»
About - Third Harmonic Bio
[email protected]. SAN FRANCISCO (Corporate Headquarters) 1700 Montgomery Street, Suite #210 San Francisco, CA 94111. CAMBRIDGE 130 Prospect Street, Cambridge, โฆSee details»
Third Harmonic Bio Announces Leadership Changes
Oct 31, 2023 Additionally, the company announced that Robert Ho, Chief Financial Officer, will depart the organization on November 10, 2023. The company has initiated executive searches โฆSee details»
Third Harmonic Bio, Inc. - Drug pipelines, Patents, Clinical trials ...
For more information, please visit the Third Harmonic Bio website: www.thirdharmonicbio.com. Investor and Media Contact:Lori [email protected] . ... The statistics โฆSee details»
Third Harmonic Bio Company Profile - Office Locations ... - Craft
Oct 29, 2024 Third Harmonic Bio has 1 employees at their 1 location. See insights on Third Harmonic Bio including office locations, competitors, revenue, financials, executives, โฆSee details»
Third Harmonic Bio - Work in biotech
Third Harmonic Bio is developing treatments for the development of allergic and inflammatory diseases. Inflammatory diseases collectively affect millions of people worldwide and are โฆSee details»
Investors & media - Third Harmonic Bio
[email protected] SAN FRANCISCO (Corporate Headquarters) 1700 Montgomery Street, Suite #210 San Francisco, CA 94111 CAMBRIDGE 130 Prospect StreetSee details»
Third Harmonic Bio - VentureRadar
Website: https://thirdharmonicbio.com. Develops a novel oral treatment for severe allergy and inflammation using a selective, oral small-molecule KIT inhibitor, THB001. VentureRadar โฆSee details»
Third Harmonic Bio Announces Leadership Changes - BioSpace
Oct 31, 2023 Additionally, the company announced that Robert Ho, Chief Financial Officer, will depart the organization on November 10, 2023. The company has initiated executive searches โฆSee details»
Third Harmonic Bio - Bain Capital Life Sciences
Thirdharmonicbio.com. THEME. Inflection Capital. STATUS. Former . Third Harmonic Bio is a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory โฆSee details»
Third Harmonic Bio, Inc. (Third Harmonic Bio, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Third Harmonic Bioโs lead product candidate, THB335, is a titratable, oral, small molecule inhibitor that is currently in a Phase 1 clinical trial. For more information, please visit the Third โฆSee details»
Third Harmonic Bio Inc. - Cruelty Free Investing
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory โฆSee details»
Third Harmonic Bio Announces Leadership Changes
Oct 31, 2023 Additionally, the company announced that Robert Ho, Chief Financial Officer, will depart the organization on November 10, 2023. ... www.thirdharmonicbio.com. Forward โฆSee details»
Science - Third Harmonic Bio
Presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress A Phase 1b, Open-label Study in Patients with Cold Urticaria โฆSee details»
Tri-omic single-cell mapping of the 3D epigenome and ... - Nature
1 day ago This work introduces ChAIR, a droplet-based tri-omic tool that enables the simultaneous profiling of the transcriptome, chromatin accessibility and chromatin โฆSee details»